A- A A+
NIPER
HAJIPUR

Dr. Narmada Vallakeerthi

Dr. Narmada Vallakeerthi

Assistant Professor

Department: Pharmaceutical Analysis

Institute: National Institute of Pharmaceutical Education & Research Hajipur,
Bihar, India – 844 102

Email: narmada[dot]vallakeerthi[at]niperhajipur[dot]ac[dot]in;
rishikaravi[at]gmail.com

Dr. Narmada Vallakeerthi

Faculty CV

  • 2023: Doctor of Philosophy (PhD) in Pharmaceutical Sciences, Faculty of Pharmaceutical Sciences, University College of Technology, Osmania University, Hyderabad-500007, India.
  • 2011: Master of Pharmacy (M.Pharm) in Pharmaceutical Analysis, Department of Pharmacy, University College of Technology, Osmania University, Hyderabad-500007, India.
  • 2006: Bachelor of Pharmacy (B.Pharm), Sarojini Naidu Vanitha Pharmacy Maha Vidyalaya, Osmania University, Hyderabad, India.

  • Impurity Profiling – Residual Solvent Analysis.
  • Analytical and Regulatory Research – Analytical, Bio-analytical and Degradation Studies.
  • Quality by Design (QbD) and Design of Experiments (DoE).
  • Green Analytical Chemistry.
  • Phytopharmaceutical Standardization.
  • Nutraceutical Development (Women’s Health – Anemia Focus).

  • Assistant Professor, Department of Pharmaceutical Analysis, National Institute of Pharmaceutical Education and Research (NIPER)-Hajipur, Bihar
    03rd September 2025 – Present.
  • Assistant Professor, Department of Pharmacy, University College of Technology, Osmania University, Hyderabad, Telangana, India
    December 2011 – August 2025.
  • Assistant Manufacturing Chemist, Pharma Deep Remedies, Hyderabad, Telangana, India
    July 2006 – September 2009.

  • Registered Pharmacist, Certificate No. 048208, State Pharmacy Council, Telangana.
  • Appointed as a PCI Inspector, Pharmacy Council of India, 2024.
  • Life Member, Indian Pharmacy Graduates Association, Certificate No. LM-7187, 28-08-2021.
  • Life Member, Association of Pharmacy Professionals, No. APP/TS/LM-225/22, 13-12-2022.
  • Member, International Association of Academic Plus Corporate (IAAC), Annual Membership AY-2022, No. FRTJQC-CE006281.
  • Member, Society of Pharmaceutical Sciences and Research, 2024, No. SPSR/AM/24-18.

  • Best Paper Award, Department of Physics, Government Holkar Science College, Indore (Madhya Pradesh), 2020.
  • Best Poster Award, Recent Advances in Chemical Engineering-2020, Golden Jubilee Celebrations of UCT, OU in association with IIChE-HRC, 2020.
  • Best Paper Award, APP Karnataka State Branch in collaboration with APP American International Branch & APP Analytical Chemistry Division, 2022.
  • Savitribai Phule Prathiba Puraskar (Best Teacher Award 2024) from Hon’ble Minister Dr. Seethakka, by Bharathiya OBC Samakhya and Telangana Journalist Welfare Society, Hyderabad, Telangana.
  • Prathibha Award from the Hon’ble President of Akhila Bharatha Sangam, 2024, Faculty Club, Osmania University, Hyderabad, Telangana.

  • German Patent: “Novel Sensitive and Advanced Clinical Mass Spectrometry Kit for Evaluation of Vitamin D Deficiency”, Application No. 202022105300 (Granted), 2022.

  • Analytical Investigation and Pharmacological Investigation of Spodias Tuberosa, Potential Areas of Research in the Pharmacognosy, Academic Decipher Press, Mumbai, ISBN: 978-81-958127-5-2, First Edition, 2023.
  • India of my Dreams, Book of Scientific and Non-Scientific Essays, Academic Decipher Press, Mumbai, ISBN: 978-81-958127-9-0, First Edition, 2023.

  • Keynote Speaker, Three Days Hands-on Training Programme on HPLC, UV-Vis Spectroscopy and FTIR Techniques, sponsored by DBT BUILDER Program, at Prof. T. Navaneeth Rao Central Facilities for Research and Development, Osmania University, Hyderabad, 2024.
  • Session Chair, National Level “TECHNOSMANIA-2K24”, organized by University College of Technology, Osmania University, Hyderabad, Telangana, 2024.
  • Invited Speaker, National Conference “Emerging Trends in Chemical Materials Sciences Research (ETCMSR-2022)”, 25th–26th February 2022.
  • Keynote Speaker, National Level World Pharmacists Day 2022, in association with Indian Pharmacy Graduates’ Association, Telangana State Branch — theme “Pharmacy United in Action for a Healthier World”.
  • Resource Person, International Conference on “Ultrasonics and Material Science for Advanced Technology” 2022, organized by Telangana University, Nizamabad, in association with Ultrasonics Society of India, New Delhi.
  • Session Chair, Two-Day National Conference on “Emerging and Adaptable Technologies in Process Industries”, in association with IIChE-HRC, UCT OU Student Chapter, organized by Research Development and Innovation Cell, UCT(A), OU, 2021.

  • Integrative Greenness, Blueness and Whiteness Determination of Analytical RP-HPLC Method for Identifying Imipenem, Cilastatin and Relebactam in Combined Tablet Form Followed by Forced Degradation Studies, Green Analytical Chemistry, vol. 11, 2024. IF: 6.2
  • Greener and Whiter Analytical Method Development and Validation of Zolpidem Tartrate Infused in Apple Juice using RP-HPLC via Magnetic Solid Phase Extraction Followed by LC-MS Confirmatory Analysis, RSC Advances, 14, 28168–28181, 2024. IF: 4.6
  • Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Determination of Selected Drugs Using Green Assessment in Bulk and Pharmaceutical Dosage Form, Asian Journal of Green Chemistry, 8, 478–496, 2024. IF: 1.6
  • Simultaneous RP-HPLC Estimation, Validation and Stability Indicating Assay of Two-Component Tablet Formulation Containing Grazoprevir and Pibrentasvir, International Journal of Pharmaceutical Quality Assurance, 15(2), 895–900, 2024.
  • Stability Indicating Method Development and Validation of Green RP-HPLC Method for Simultaneous Estimation of Metformin, Teneligliptin, and Pioglitazone in Bulk and Pharmaceutical Dosage Forms by Evaluation of Greenness, Asian Journal of Green Chemistry, vol. 8, 2024. IF: 1.6
  • Analytical Method Development and Validation for Simultaneous Estimation of Olmesartan and Rosuvastatin in Pure and Pharmaceutical Dosage Form by Using RP-HPLC, International Journal of Biology, Pharmacy, and Allied Sciences, 12(10), 4542–4553, 2023.
  • Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Bilastine and Montelukast in Tablet Dosage Form, Chemical Science International Journal, 32(3), 52–61.
  • RP-HPLC Method Development, Validation Including Stability Indicating and Forced Degradation Studies for the Estimation of Pemetrexed in API and Pharmaceutical Dosage Form, Journal of Physics: Conference Series, vol. 2603, 012055, IOP Publishing, 2023.
  • Development and Validation of Stability Indicating RP-HPLC Method for Simultaneous Determination of Anti-Haemorrhagic Ethamsylate and Anti-Fibrinolytic Tranexamic Acid in Combined Formulation Using Green Assessment, Journal of Chemical Health Risks, 13(4), 1084–1103, 2023.
  • A Study on the Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Emtricitabine, Tenofovir Disoproxil Fumarate, and Efavirenz in Both Bulk and Pharmaceutical Formulations, European Chemical Bulletin, 12(4), 886–900.
  • Method Validation for Quantification of Lopinavir in Human Plasma by Using LC-MS/MS, European Journal of Molecular & Clinical Medicine, 10(01), 1115–1133, 2023.
  • Spectrophotometric Method and Its Validation for Tolvaptan in Its Bulk and Marketed Formulation Including Stress Studies, International Journal of Drug Delivery Technology, 13(1), 216–220, 2023.
  • Development and Validation of a Stability Indicating Green Analytical Method for the Simultaneous Estimation of Ambroxol and Loratadine in Bulk and Pharmaceutical Dosage Forms by RP-HPLC, Bulletin of Environment, Pharmacology and Life Sciences, 13(1), 129–140, 2023.
  • HS-GC-FID Method Development and Validation for Quantification of Residual Solvents in Favipiravir, Journal of Pharmaceutical Negative Results, 13(10), 3675–3685, 2022. DOI: 10.47750/pnr.2022.13.S10.445
  • Jak Inhibitors: Role and Applications for the Treatment of Multifactorial Diseases, High Technology Letters, 28(3), 236–246, 2022.
  • Stability Indicating Method Development and Validation, Stress Degradation Studies for Dacarbazine by Using RP-HPLC, NeuroQuantology, 20(9), 6270–6278, 2022.
  • Method Development and Validation of Secnidazole, Fluconazole and Azithromycin in Tablet Dosage Form by RP-HPLC Method, High Technology Letters, 28(1), 711–729, 2022.
  • Method Development, Validation, Identification and Quantification of Residual Solvents in Phenazopyridine Hydrochloride Using Head Space–Gas Chromatography Technique, AIP Conference Proceedings, 2369, 020171-9, 2021.
  • RP-HPLC Method Development and Validation for Determination of Tigecycline in Bulk and Pharmaceutical Dosage Form, Journal of Pharmaceutical Research International, 33(39), 273–282, 2021.
  • Sensor Applications in Analysis of Drugs and Formulations, Asian Journal of Pharmaceutical and Clinical Research, 14(11), 21–23, 2021.
  • Development and Validation of RP-HPLC Method in Simultaneous Estimation of Lamivudine and Abacavir as Tablet Dosage Form, Journal of Critical Reviews, 7(2), 1358–1370, 2020.
  • Role of Metallic Nanoparticles in Cardiovascular Disease, Journal of Cardiovascular Disease Research, 11(03), 162–172, 2020.
  • Pharmacological and Neuroprotective Activity of Smilax zeylanica, Carissa macrocarpa and Thespesia lampas, Journal of Critical Reviews, 6(06), 556–562, 2019.
  • Development and Validation of a RP-HPLC Method for the Simultaneous Determination of Netupitant and Palonosetron in Pure and Pharmaceutical Dosage Form, Indo American Journal of Pharmaceutical Sciences, 05(12), 17584–17593, 2018.
  • A Review on Application of Different Polymers in Controlled Release Matrix Formulations, Journal of Cardiovascular Disease Research, 08(03), 112–124, 2017.